Erika Carmel Ltd (BCUR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Erika Carmel Ltd (BCUR) has a cash flow conversion efficiency ratio of 0.113x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA1.52 Million ≈ $4.07K USD) by net assets (ILA13.40 Million ≈ $35.92K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Erika Carmel Ltd worth for the company's overall valuation and market capitalisation.
Erika Carmel Ltd - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Erika Carmel Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Erika Carmel Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Erika Carmel Ltd ranked by their cash flow conversion efficiency. Explore Erika Carmel Ltd cash earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Desert Control AS
OL:DSRT
|
-0.415x |
|
PREMIER1 Lithium Ltd
AU:PLC
|
-0.106x |
|
Genesis Resources Ltd
AU:GES
|
-0.764x |
|
THREED CAPITAL INC.
F:B5K3
|
N/A |
|
TaoWeave Inc.
NASDAQ:TWAV
|
-0.098x |
|
Braster S.A.
WAR:BRA
|
-0.048x |
|
MAST ENERGY DEV. LS -001
F:97D
|
N/A |
|
Eterna Therapeutics Inc
NASDAQ:ERNA
|
-1.298x |
Annual Cash Flow Conversion Efficiency for Erika Carmel Ltd (2019–2024)
The table below shows the annual cash flow conversion efficiency of Erika Carmel Ltd from 2019 to 2024. View BCUR stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ILA15.04 Million ≈ $40.31K |
ILA-4.22 Million ≈ $-11.33K |
-0.281x | +25.70% |
| 2023-12-31 | ILA23.73 Million ≈ $63.61K |
ILA-8.97 Million ≈ $-24.06K |
-0.378x | +52.26% |
| 2022-12-31 | ILA42.67 Million ≈ $114.39K |
ILA-33.80 Million ≈ $-90.61K |
-0.792x | -142.64% |
| 2021-12-31 | ILA88.06 Million ≈ $236.09K |
ILA-28.75 Million ≈ $-77.08K |
-0.326x | -116.08% |
| 2020-12-31 | ILA8.97 Million ≈ $24.05K |
ILA18.21 Million ≈ $48.81K |
2.030x | +11.65% |
| 2019-12-31 | ILA3.11 Million ≈ $8.33K |
ILA5.65 Million ≈ $15.14K |
1.818x | -- |
About Erika Carmel Ltd
Erika B-Cure Laser Ltd develops, manufactures, markets, distributes, and sells the B-Cure laser products in Israel and internationally. It offers B-Cure Laser Classic, a home medical device for the treatment of pain, orthopedic problems, dermatology, analgesia, inflammation, and wound healing; and B-Cure Laser Pro, a device for the treatment of acute and chronic problems, such as orthopedic probl… Read more